Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study. (2023)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s41512-023-00155-z
PubMed Identifier: 37697410
Publication URI: http://europepmc.org/abstract/MED/37697410
Type: Journal Article/Review
Volume: 7
Parent Publication: Diagnostic and prognostic research
Issue: 1
ISSN: 2397-7523